Insulin Analog
60 drugs across 5 manufacturers|17 Generic,43 Brand
The Insulin Analog class contains 60 NDCs from 5 manufacturers (17 generic, 43 brand), at an average NADAC of $16.00 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
60
17G / 43B
Manufacturers
5
Avg $16.0009/unit
Avg 7d Change
+0.02%
Across 32 drugs with changes
7d Activity
of 60 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Insulin Analog class?
The Insulin Analog class contains 60 NDCs from 5 manufacturers — 17 generic and 43 brand products.
What is the average price of Insulin Analog drugs?
The average NADAC for the Insulin Analog class is $16.0009 per unit across 60 NDCs.
Is generic cheaper than brand in the Insulin Analog class?
The average generic NADAC in this class is $11.5180 per unit, versus $17.7733 for brand — generic is about 35% cheaper on average.
Which manufacturers make Insulin Analog drugs?
5 manufacturers make drugs in the Insulin Analog class. Ranked by number of NDCs, the largest are Novo Nordisk (23), Eli Lilly and Company (20), Sanofi-Aventis U.S. LLC (12), Biocon Biologics Inc. (4), Winthrop U.S. (1).
How has Insulin Analog pricing changed recently?
Over the past 7 days, 14 NDCs in this class rose and 18 fell, with a class-wide average change of +0.0%.
Manufacturer Breakdown
5 manufacturers producing drugs in this therapeutic class(1 pricing outlier)